Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Medpace Holdings is a global clinical contract research organization (CRO) providing outsourced drug development services. Medpace provides a...
— C.T. Fitzpatrick
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Medpace Holdings, Inc.
Our investments in drug development companies like Charles River Labs (CRL) and Medpace Holdings (MEDP) pulled back, driven by AI disruption fears.
Medpace posted strong Q2 results that beat expectations on both top and bottom lines, leading to a full-year guidance upgrade. Furthermore, massive share...
Medpace continues to outperform expectations by winning business awards and expanding free cash flow despite biotech funding noise. A debt-free balance...
More institutional theses from Vulcan Value Partners - Large Cap
Sodexo is a leading global food services provider characterized by long-term contracts, high customer retention, and stable cash flows. Corporate actions to...
Stanley Black & Decker is a leading global tools manufacturer with robust brands and substantial market share. A comprehensive cost...
TPG is an alternative asset manager poised to benefit from long-term private market capital flows and annuity-like fees. The company's exceptional...